Title : Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance).

Pub. Date : 2018 Oct 1

PMID : 29871907






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In vitro overexpression of SLC29A1 in human endothelial cells disrupted adenosine signaling and reduced nitric oxide levels that were further lowered upon bevacizumab exposure.Conclusions: The genomic region between SLC29A1 and HSP90AB1 and its role in regulating adenosine signaling are key targets for further investigation into the pathogenesis of bevacizumab-induced hypertension. Nitric Oxide solute carrier family 29 member 1 (Augustine blood group) Homo sapiens